FDA Person
FDARafeeq A. Habeeb
View detailed information about Rafeeq A. Habeeb, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 57 inspections of 56 companies, 2018–2026.
Inspections (57)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 15, 2026 | AXXELENT PHARMA SCIENCE PRIVATE LIMITED | Not classified | #1341844 | |
| February 20, 2026 | ACME GENERICS PRIVATE LIMITED | Not classified | Drug Quality Assurance | #1305200 |
| January 16, 2026 | Dabur India Limited | OAI | Drug Quality Assurance | #1299974 |
| December 17, 2025 | APL HEALTHCARE LIMITED | VAI | Drug Quality Assurance | #1295002 |
| November 13, 2025 | Zydus Lifesciences Limited | VAI | Generic Drug Evaluation | #1291548 |
| November 1, 2025 | Naari Pharma Private Limited | Not classified | Drug Quality Assurance | #1289782 |
| September 26, 2025 | Honour Lab Limited | Not classified | #1285710 | |
| September 26, 2025 | M/S, Sygmoslab Private Limited | Not classified | Drug Quality Assurance | #1284922 |
| July 17, 2025 | Lupin Limited | VAI | Drug Quality Assurance | #1275680 |
| July 17, 2025 | Lupin Limited | Not classified | Drug Quality Assurance | #1275446 |
| July 4, 2025 | Alchem International Ltd. | Not classified | #1279310 | |
| June 20, 2025 | Maithri Drugs Private Limited | Not classified | #1276808 | |
| May 20, 2025 | Eli Lilly & Company | VAI | Drug Quality Assurance | #1270621 |
| April 25, 2025 | Q LABS, LLC | VAI | Drug Quality Assurance | #1268075 |
| March 21, 2025 | Aprecia Pharmaceuticals LLC | VAI | Drug Quality Assurance | #1264269 |
| March 4, 2025 | Kutol Products Company, Inc. | OAI | Drug Quality Assurance | #1256355 |
| January 21, 2025 | Resilience US, Inc. | VAI | Drug Quality Assurance | #1258820 |
| September 4, 2024 | Wuhan Hongren Biopharmaceutical Inc. | Not classified | #1251337 | |
| August 30, 2024 | Huangshi Hygienic Material Medicine Co., Ltd. | OAI | Drug Quality Assurance | #1250004 |
| August 23, 2024 | Chongqing Sintaho Pharmaceutical Co., Ltd. | Not classified | #1249937 |
Documents (45)
- 483 · Dabur India Limited · January 16, 2026
- 483 · Laurus Synthesis Private Limited · December 12, 2023
- 483 · Lupin Limited · July 17, 2025
- 483 · KP Pharmaceutical Technology · March 11, 2024
- 483 · Honour Lab Limited · September 26, 2025
- EIR · Jubilant HollisterStier General Partnership · February 28, 2023
- 483 · Jyoti Simple Solutions Private Limited · August 11, 2022
- 483 · Bora Pharmaceuticals Inc. · July 11, 2024
- 483 · APL HEALTHCARE LIMITED · December 17, 2025
- 483 · Aeropres Corp · June 27, 2023
- 483 · Camco Chemical Company · March 2, 2022
- 483 · Zydus Lifesciences Limited · November 13, 2025
- 483 · SnugZ USA, Inc. · September 17, 2021
- 483 · Megafine Pharma (P) Limited · May 8, 2023
- 483 · Eli Lilly & Company · May 20, 2025
- 483 · Resilience US, Inc. · January 21, 2025
- 483 · Naari Pharma Private Limited · November 1, 2025
- 483 · Kutol Products Company, Inc. · March 4, 2025
- 483 · Q LABS, LLC · April 25, 2025
- 483 · BOEHRINGER INGELHEIM PROMECO S.A. de C.V. · May 20, 2022
- 483 · Aprecia Pharmaceuticals LLC · March 21, 2025
- 483 · Piramal Pharma Solutions Inc. · January 10, 2023
- 483 · Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. · August 1, 2023
- 483 · KP Pharmaceutical Technology · March 21, 2024
- 483 · Thorn BioScience LLC · May 22, 2024
- 483 · Rxhomeo Private Limited · May 15, 2023
- 483 · Degasa S.A. De C.V. · May 27, 2022
- 483 · Eli Lilly & Company · March 16, 2021
- 483 · Laurus Synthesis Private Limited
- 483 · Glenfin Chemicals Private Ltd. · August 19, 2022
- 483 · Yusef Manufacturing Laboratories, LLC · September 24, 2021
- 483 · Jubilant HollisterStier General Partnership · February 28, 2023
- 483 · Lupin Limited · July 17, 2025
- 483 · Haney, Inc. · October 18, 2022
- EIR · Allergan Sales LLC · June 24, 2021
- 483 · KP Pharmaceutical Technology · February 3, 2023
- 483 · Catalent Indiana, LLC · November 15, 2023
- 483 · Strides Pharma Science Limited · May 20, 2026
- 483 · Lambda Research, Inc. · August 26, 2022
- 483 · Strides Pharma Science Limited
- 483 · USV Private Limited
- 483 · Wanbury Limited · July 13, 2026
- 483 · Huangshi Hygienic Material Medicine Co., Ltd. · August 30, 2024
- 483 · Glenmark Pharmaceuticals Limited · June 22, 2026
- 483 · Wuhan Hongren Biopharmaceutical Inc. · September 4, 2024
Frequently inspected with (10)
Lisa L. Flores
Consumer Safety Officer/ Federal Investigator
5 shared
Logan T. Williams
Investigator
4 shared
Martin M. Kimani
3 shared
Donna K. Speer
2 shared
Guerlain Ulysse
Investigator
2 shared
Jacob G. Lutz
Investigator
2 shared
Jennifer R. Johnson
Consumer Safety Officer
2 shared
Joseph A. Piechocki
2 shared
Mancia R. Walker
2 shared
Saleem A. Akhtar
2 shared
Person Information
Name
Rafeeq A. Habeeb
Title
Investigator
Role
Regulatory Personnel
ID: ac58c0b7-bd42-4037-8ccb-bf0351b7744f
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.